M402, a heparan sulfate mimetic and novel candidate for the treatment of pancreatic cancer

被引：0
|
作者：
Schultes, Birgit Corinna
Lolkema, Martijn P. J. K.
Chu, Chia Lin
Zhou, He
Long, Alison
Lockley, Michelle
Avery, William
Kurtagic, Elma
Galcheva-Gargova, Zoya
Miller, Paul
Duffner, Jay
Maschek, Birgit J.
Jarlenski, Donna
Tuveson, David A.
Roach, Jim
Venkataraman, Ganesh
Kishimoto, Takashi K.
Flaherty, Keith T.
机构：
[1] Momenta Pharmaceut, Cambridge, MA USA
[2] Univ Med Ctr Utrecht, Utrecht, Netherlands
[3] Univ London, CRUK Queen Mary, London, England
[4] Adjuvantis LLC, Windham, NH USA
[5] CRUK Cambridge, Cambridge, England
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4056
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Novel Targeted Biotherapeutic for Treatment of Pancreatic Cancer
    Qi, X.
    Chu, Z.
    Palascak, M. B.
    Franco, R. S.
    Stringer, K. F.
    Ahmad, S. A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S6 - S6
  • [32] Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer
    Song, Kai
    Li, Qin
    Jiang, Zhen-Zhen
    Guo, Chao-Wei
    Li, Ping
    CANCER BIOLOGY & THERAPY, 2011, 12 (05) : 388 - 398
  • [33] An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer
    Jia, Jinping
    Parikh, Hemang
    Xiao, Wenming
    Hoskins, Jason W.
    Pflicke, Holger
    Liu, Xuelu
    Collins, Irene
    Zhou, Weiyin
    Wang, Zhaoming
    Powell, John
    Thorgeirsson, Snorri S.
    Rudloff, Udo
    Petersen, Gloria M.
    Amundadottir, Laufey T.
    BMC MEDICAL GENOMICS, 2013, 6
  • [34] An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer
    Jinping Jia
    Hemang Parikh
    Wenming Xiao
    Jason W Hoskins
    Holger Pflicke
    Xuelu Liu
    Irene Collins
    Weiyin Zhou
    Zhaoming Wang
    John Powell
    Snorri S Thorgeirsson
    Udo Rudloff
    Gloria M Petersen
    Laufey T Amundadottir
    BMC Medical Genomics, 6
  • [35] Herceptin treatment - A novel treatment modality in pancreatic cancer.
    Buechler, P
    Hines, JO
    Buechler, MC
    Friess, H
    Roth, MM
    Isacoff, WH
    GASTROENTEROLOGY, 2000, 118 (04) : A1055 - A1055
  • [36] Cystatin M: A novel candidate tumor suppressor gene for breast cancer
    Zhang, J
    Shridhar, R
    Dai, Q
    Song, J
    Barlow, SC
    Yin, LJ
    Sloane, BF
    Miller, FR
    Meschonat, C
    Li, BDL
    Abreo, F
    Keppler, D
    CANCER RESEARCH, 2004, 64 (19) : 6957 - 6964
  • [37] Heat shock factor 1: A potential therapeutic candidate for the treatment of pancreatic cancer
    Dudeja, V.
    Chugh, R.
    Yokoyama, Y.
    Talukdar, R.
    Borja-Cacho, D.
    Zwolak, P.
    Dawra, R.
    Vickers, S.
    Saluja, A.
    PANCREAS, 2007, 35 (04) : 399 - 399
  • [38] Aurora kinase A inhibition in combination with proapoptotic BH3-mimetic for treatment of pancreatic cancer
    Kim, Edward Jae-Hoon
    Chinn, Danielle C.
    Semrad, Thomas John
    Mack, Philip C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [39] The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics
    Hammond, Edward
    Khurana, Ashwani
    Shridhar, Viji
    Dredge, Keith
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [40] The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
    Dredge, K.
    Hammond, E.
    Davis, K.
    Li, C. P.
    Liu, L.
    Johnstone, K.
    Handley, P.
    Wimmer, N.
    Gonda, T. J.
    Gautam, A.
    Ferro, V.
    Bytheway, I.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (03) : 276 - 283
12345